Pay Your Bill Online Test Menu Test Results Online LabCare Plus Results

Oxidized LDL Triple Marker Test

Download Brochure

Shiel’s Oxidized LDL Triple Marker Test offers the most powerful combination of biomarkers for identifying patients with Coronary Artery Disease (CAD). This clinically proven, innovative Cardiovascular Disease risk assessment test is a potential replacement for all current blood lipid tests, including Total Cholesterol and LDL-Cholesterol.  The Oxidized LDL Triple Marker Test is the only blood test that identifies Atherosclerotic Disease activity in the artery wall.

Pathophysiological Component Corresponding Biomarker

1. Atherogenesis - Oxidized LDL (OxLDL)
2. Anti-Atherogenesis - High-Density Lipoprotein (HDL)
3. Inflammation - High-Sensitivity CRP (hs-CRP)

Lowering CAD Risks in Patients

Patient compliance is improved when patients understand the test being performed. Lowering the Triple Marker Test result, and thus lowering CAD risk, is attainable through conventional treatments (dietary/lifestyle changes plus statins, if required).  As shown in Fig. 1 the Oxidized LDL Triple Marker Test is significantly more effective than other currently available laboratory tests in identifying patients with CAD.  Thus, the Oxidized LDL Triple Marker Test result should be especially useful in monitoring patients who modify their diet and lifestyle and/or receive therapeutic lipid-lowering medications.